Samstag, 14. März 2009

In Re Bradley Pharmaceuticals, Inc. Securities Litigation

Trading Symbol: N/A
CUSIP Number: N/A

TERMS OF THE SETTLEMENT: The Settlement consists of $3,500,000 in cash and will include interest on the Settlement Fund prior to distribution.

CLASS DESCRIPTION: All persons who purchased the common stock of Bradley Pharmaceuticals, Inc. during the period from October 28, 2004 through February 25, 2005, inclusive.

IMPORTANT DATES:

DATE TO SEEK EXCLUSION
FROM THE CLASS: MAY 20, 2009

DATE FOR SUBMISSION OF
PROOF OF CLAIM FORMS: JULY 20, 2009

TO OBTAIN A PROOF OF CLAIM FORM:

Robert M. Roseman, Esquire
SPECTOR, ROSEMAN KODROFF & WILLIS, P.C.
Tel: 215-496-0300
Fax: 215-496-6611
Email: rroseman@srkw-law.com

Keine Kommentare: